FCGCX
Price
$20.48
Change
+$0.06 (+0.29%)
Updated
Sep 5 closing price
Net Assets
895.5M
PRNEX
Price
$41.35
Change
+$0.10 (+0.24%)
Updated
Sep 8 closing price
Net Assets
2.39B
Interact to see
Advertisement

FCGCX vs PRNEX

Header iconFCGCX vs PRNEX Comparison
Open Charts FCGCX vs PRNEXBanner chart's image
Fidelity Advisor Global Commodity Stk C
Price$20.48
Change+$0.06 (+0.29%)
VolumeN/A
Net Assets895.5M
T. Rowe Price New Era
Price$41.35
Change+$0.10 (+0.24%)
VolumeN/A
Net Assets2.39B
FCGCX vs PRNEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FCGCX vs. PRNEX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCGCX is a Hold and PRNEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRNEX has more cash in the bank: 2.4B vs. FCGCX (895M). PRNEX pays higher dividends than FCGCX: PRNEX (1.86) vs FCGCX (1.20). FCGCX was incepted earlier than PRNEX: FCGCX (16 years) vs PRNEX (57 years). FCGCX (1.90) is less costly to investors than PRNEX (0.77). FCGCX is a more actively managed with annual turnover of: 49.00 vs. PRNEX (24.30). FCGCX has a lower initial minimum investment than PRNEX: FCGCX (0) vs PRNEX (2500). FCGCX annual gain was more profitable for investors over the last year : 14.21 vs. PRNEX (7.54). FCGCX return over 5 years is better than : 92.93 vs. PRNEX (58.81).
FCGCXPRNEXFCGCX / PRNEX
Total Expense Ratio1.900.77247%
Annual Report Gross Expense Ratio1.900.77247%
Fund Existence16 years57 years-
Gain YTD14.41311.006131%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRA500N/A-
Net Assets895M2.4B37%
Annual Yield % from dividends1.201.8664%
Returns for 1 year14.217.54189%
Returns for 3 years14.9012.40120%
Returns for 5 years92.9358.81158%
Returns for 10 years116.0566.53174%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KYTX3.940.31
+8.54%
Kyverna Therapeutics
BMA58.910.69
+1.19%
Banco Macro SA
DXCM80.51-0.25
-0.31%
DexCom
AMS2.51-0.04
-1.57%
American Shared Hospital Services
CAPL20.56-0.44
-2.10%
CrossAmerica Partners LP